Congratulations to Charles Maack, recipient of the PCRI 2012 "Harry Pinchot" Award
2008 recipient of the Us TOO Intl., Inc. "Edward C. Kaps Hope Award”
Welcome to The Prostate Advocate website. This site is dedicated to providing useful resources towards understanding prostate cancer, its treatment, and the treatment of the side effects of most treatment options. The papers on the "Observations" page have been authored or compiled by Charles (Chuck) Maack, Prostate Cancer survivor, continuing patient since 1992, advocate, and mentor, or papers provided by Medical Professional friends. Physicians and patients have suggested he put the information together in a book. Chuck says that this IS his "book," prepared with patients and caregivers in mind for easy access to subjects available reasonably alphabetically and as comprehensive as possible. That reasoning compliments the words he most always includes in his signature block when addressing patient or caregiver concerns: "Always as close as the other end of your computer to help address any Prostate Cancer concerns." To know more about Chuck please click HERE
Please recognize that I am not a Medical Doctor. I have been an avid student researching and studying prostate cancer as a survivor and continuing patient since 1992. I have dedicated my retirement years to continued research and study in order to serve as an advocate for prostate cancer awareness, and, from a activist patient's viewpoint, to help patients, caregivers, and others interested develop an understanding of prostate cancer, its treatment options, and the treatment of the side effects that often accompany treatment. Readers of this paper must understand that the comments or recommendations I make are not intended to be the procedure to blindly follow; rather, they are to be reviewed as my opinion, then used for further personal research, study, and subsequent discussion with the medical professional/physician providing prostate cancer care.
In the following interview, during the 2009 PCRI Conference on Prostate Cancer, I made a couple mistakes in my answers to a couple questions. When I was explaining androgen receptors not being blocked, I stated “by LHRH agonists” when I meant to say “antiandrogens.” And when speaking in support of triple hormonal blockade (ADT3), I forgot to name the third medication to be a 5Alpha Reductase (5AR) Inhibitor, either dutasteride/Avodart (preferred), or alternatively, finasteride/Proscar, to inhibit testosterone coming in contact with 5AR isoenzymes where it would otherwise convert to the much more powerful stimulant to cancer cell growth, dihydrotestosterone (DHT).